Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Ann Thorac Surg ; 70(3): 966-8; discussion 968-9, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11016346

RESUMEN

We report a tricky case of endocarditis because of the localization, aortic coarctation, and the pathogenic bacteria Actinobacillus actinomycetemcomitans. Furthermore, we underline the leading role of transesophageal echocardiography in the diagnosis of aortic endarteritis. First, aortitis was treated with antibiotics and, second, successfully operated on.


Asunto(s)
Infecciones por Actinobacillus/complicaciones , Aggregatibacter actinomycetemcomitans , Aneurisma Falso/complicaciones , Coartación Aórtica/complicaciones , Enfermedades de la Aorta/complicaciones , Endarteritis/complicaciones , Adulto , Aneurisma Falso/diagnóstico por imagen , Ecocardiografía Transesofágica , Humanos , Masculino
2.
Rev Med Interne ; 14(10): 986, 1993.
Artículo en Francés | MEDLINE | ID: mdl-8009079

RESUMEN

In an attempt to further characterize infections due to Xanthomonas maltophilia (XM), we reviewed 50 case reports observed in our institution. XM is emerging as an important nosocomial pathogen in immunocompromised patients, especially those receiving broad spectrum antimicrobial antibiotherapy. Distinction between colonisation and infection is often difficult. XM presents a therapeutic challenge because of its tendency to exhibit multiple resistance.


Asunto(s)
Infección Hospitalaria/microbiología , Huésped Inmunocomprometido , Xanthomonas/patogenicidad , Adulto , Anciano , Infección Hospitalaria/inmunología , Femenino , Humanos , Masculino , Persona de Mediana Edad
3.
Rev Med Interne ; 15(12): 808-12, 1994.
Artículo en Francés | MEDLINE | ID: mdl-7863115

RESUMEN

In an attempt to further characterize infections due to Xanthomonas maltophilia, we reviewed 20 colonisations and 30 infections observed in our institution from january 1990 to december 1992, Xanthomonas maltophilia is emerging as an important nosocomial pathogen in immunocompromised patients, especially those receiving broad spectrum antimicrobial antibiotherapy. Distinction between colonisation and infection is often difficult. Xanthomonas maltophilia presents a therapeutic challenge because of its tendency to exhibit multiple resistance.


Asunto(s)
Infección Hospitalaria/microbiología , Xanthomonas , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacteriemia/etiología , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/etiología , Resistencia a Múltiples Medicamentos , Femenino , Humanos , Huésped Inmunocomprometido , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Xanthomonas/efectos de los fármacos , Xanthomonas/aislamiento & purificación
4.
Rev Med Interne ; 20(8): 701-4, 1999 Aug.
Artículo en Francés | MEDLINE | ID: mdl-10480174

RESUMEN

INTRODUCTION: Group B streptococcal meningitis is unusual in adults. It occurs in patients with a chronic disease. EXEGESIS: We report a case of group B streptococcal meningitis that occurred in a 32-year-old woman, uncovering inner ear congenital malformation associated with cerebrospinal fluid fistula. There was no recurrent episode of meningitis during a 2-year period following surgical correction of the malformation. CONCLUSION: Clinical signs suggesting cerebrospinal fluid fistula should be considered in any adult patient with severe group B streptococcal infection.


Asunto(s)
Oído Interno/anomalías , Meningitis Bacterianas/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Streptococcus agalactiae , Adulto , Oído Interno/cirugía , Femenino , Estudios de Seguimiento , Humanos , Meningitis Bacterianas/complicaciones , Infecciones Estreptocócicas/complicaciones , Factores de Tiempo
5.
Rev Med Interne ; 20(7): 607-10, 1999 Jul.
Artículo en Francés | MEDLINE | ID: mdl-10434352

RESUMEN

INTRODUCTION: Parotidean and ovarian lymphoma often indicate the existence of non-Hodgkin's lymphoma, involving 1-5% and 0.2% of the cases, respectively. EXEGENESIS: The authors report the case of a 70-year-old woman who presented B cell lymphoma of the parotid gland revealed by a rapid increase in the parotid size. CT scan showed the existence of a tumor located in the left ovary, later confirmed by biopsy. The proposed diagnosis was diffuse B cell type lymphoma with double glandular localization. Adenopathy and bone marrow involvement were both lacking. CONCLUSION: Lymphoma with glandular localizations always require diagnosis confirmation via histological examination and immunophenotyping, and must be considered as the local sign of a general disease.


Asunto(s)
Linfoma de Células B/diagnóstico , Neoplasias Ováricas/diagnóstico , Neoplasias de la Parótida/diagnóstico , Anciano , Biopsia , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias Ováricas/diagnóstico por imagen , Neoplasias de la Parótida/patología , Tomografía Computarizada por Rayos X
6.
Artículo en Inglés | MEDLINE | ID: mdl-9593457

RESUMEN

OBJECTIVE: To evaluate the effect of foscarnet on HIV-1 replication in vivo. PATIENTS AND METHODS: Seventeen AIDS patients with cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV) infection, Kaposi's sarcoma (KS), or a combination of these were treated with foscarnet. HIV RNA quantification (bDNA 2.0, Chiron, Emeryville, CA, U.S.A.), CMV pp65 antigenemia (Argene Biosoft, Varilhes, France), and CMV viremia were determined before and during therapy. RESULTS: Four patients had CMV retinitis (1 with KS), 2 patients had CMV pneumonia (1 with KS), 1 patient had CMV cholecystitis, 2 patients had VZV infection (1 with KS), 1 patient had HSV-2 infection, and 7 patients had KS alone. The decrease in HIV-1 load was -0.73 +/- 0.39 log copies/ml (p = 2.10(-6)) after 3 days of treatment and -1.15 +/- 0.49 log copies/ml (p < 10(-7)) after 10 days of treatment, compared with day 0. Furthermore, reduction of HIV-1 plasma load during foscarnet therapy did not depend on the presence or absence of CMV disease or on a positive pp65 antigenemia at day 0. CONCLUSION: We observed decreased HIV-1 plasma load in all patients treated with foscarnet, regardless of presence or absence of clinical or biologic CMV infection. This decrease supports the proposition that foscarnet anti-HIV-1 activity may be of clinical importance.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Antivirales/uso terapéutico , Foscarnet/uso terapéutico , VIH-1/efectos de los fármacos , Carga Viral , Replicación Viral/efectos de los fármacos , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Síndrome de Inmunodeficiencia Adquirida/virología , Adulto , Anciano , Antivirales/farmacología , Infecciones por Citomegalovirus/complicaciones , Femenino , Foscarnet/farmacología , VIH-1/genética , VIH-1/fisiología , Herpes Simple/complicaciones , Herpes Zóster/complicaciones , Humanos , Masculino , Persona de Mediana Edad , ARN Viral/sangre , Sarcoma de Kaposi/complicaciones , Viremia/complicaciones , Viremia/tratamiento farmacológico , Viremia/virología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda